Versor Investments’s Edwards Lifesciences EW Stock Holding History

Versor Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,857	Closed	-$1.4M	–	732
2025 Q2	$1.4M	Buy	17,857 +2,357	+15%	+$176K	0.25%	87
2025 Q1	$1.12M	Buy	+15,500	New	+$1.11M	0.18%	167
2024 Q4	–	Sell	-4,455	Closed	-$294K	–	822
2024 Q3	$294K	Buy	4,455 +2,255	+103%	+$164K	0.05%	595
2024 Q2	$203K	Sell	2,200 -4,300	-66%	-$381K	0.04%	658
2024 Q1	$621K	Buy	+6,500	New	+$546K	0.13%	269
2023 Q4	–	Sell	-4,496	Closed	-$311K	–	753
2023 Q3	$311K	Buy	4,496 +2,043	+83%	+$164K	0.06%	476
2023 Q2	$231K	Sell	2,453 -7,122	-74%	-$619K	0.04%	518
2023 Q1	$792K	Buy	+9,575	New	+$753K	0.1%	177
2022 Q2	–	Sell	-1,773	Closed	-$209K	–	834
2022 Q1	$209K	Buy	+1,773	New	+$199K	0.01%	573
2020 Q3	–	Sell	-8,448	Closed	-$584K	–	304
2020 Q2	$584K	Sell	8,448 -6,849	-45%	-$487K	0.06%	71
2020 Q1	$962K	Sell	15,297 -3,303	-18%	-$238K	0.06%	55
2019 Q4	$1.45M	Buy	+18,600	New	+$1.45M	0.07%	95

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Versor Investments's EW Position: Q3 2025 in Review

Versor Investments sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 17,857 shares — an estimated $1.4M sold.

Versor Investments first reported a position in EW in Q4 2019 and held it in 12 quarters. The position peaked at $1.45M in Q4 2019. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Versor Investments reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Versor Investments sold 17,857 Edwards Lifesciences shares in Q3 2025, an estimated $1.4M.
Versor Investments first reported a position in Edwards Lifesciences in Q4 2019 and held it in 12 quarters.
Versor Investments's Edwards Lifesciences position peaked at $1.45M in Q4 2019.
1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.